戈勒克布尔医院哮喘治疗的处方模式。
Prescription pattern in asthma therapy at Gorakhpur hospitals.
作者信息
Pandey Awanish, Tripathi Poonam, Pandey Rishabh Dev
机构信息
Division of Pharmaceutical Sciences, Institute of Technology & Management, GIDA, Gorakhpur, U.P., India.
出版信息
Lung India. 2010 Jan;27(1):8-10. doi: 10.4103/0970-2113.59261.
OBJECTIVES
This prescription-monitoring study was conducted to establish the drug-prescribing trend of anti-asthmatic drugs in various hospitals of Gorakhpur.
SETTING
The study covered three famous hospitals of Gorakhpur.
PATIENTS AND METHODS
Hundred patients were studied using a prescription auditing performa. Data was recorded from the patient's attending the out patient department using a chance random sample method for two months. Patients who co- operated were interviewed and information was filled in the performa.
RESULTS
The results suggested that b-agonist (40%) were the most frequently prescribed anti-asthmatic drugs followed by Methylxanthine (27%), corticosteroids (25%), leukotriene antagonist (4.4%) and anti-histaminics (3.6%) was the least prescribed. Analysis of prescription revealed that multiple drug therapy (81%) was opted for a significant number of patients as compared to single drug therapy (19%). Contrary to popular belief, oral dosage form tablets (56.3%) were preferred over inhalation (33.8%).
CONCLUSION
It is concluded that the present prescribing pattern of anti-asthmatics in Gorakhpur does not completely meet standard guidelines of asthma treatment. Hence there is a need to encourage physicians of Gorakhpur to follow the guidelines while treating asthma.
目的
开展这项处方监测研究，以确定戈勒克布尔各医院抗哮喘药物的处方趋势。
背景
该研究涵盖了戈勒克布尔的三家著名医院。
患者与方法
使用处方审核表对100名患者进行研究。采用机会随机抽样法，在两个月内记录门诊部就诊患者的数据。对配合的患者进行访谈，并将信息填入表格。
结果
结果表明，β受体激动剂（40%）是最常开具的抗哮喘药物，其次是甲基黄嘌呤（27%）、皮质类固醇（25%）、白三烯拮抗剂（4.4%），而抗组胺药（3.6%）的处方量最少。处方分析显示，与单一药物治疗（19%）相比，大量患者选择了联合药物治疗（81%）。与普遍看法相反，口服剂型片剂（56.3%）比吸入剂（33.8%）更受青睐。
结论
得出结论，戈勒克布尔目前抗哮喘药物的处方模式并未完全符合哮喘治疗的标准指南。因此，有必要鼓励戈勒克布尔的医生在治疗哮喘时遵循这些指南。
Zotero 插件